Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E, Dementia, And Cortical Deposition Of Beta-amyloid Protein.

T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinistö, P. Halonen, K. Kontula
Published 1995 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND The epsilon 4 allele of apolipoprotein E has been associated with an increased risk of late-onset Alzheimer's disease. In a cohort of elderly subjects we prospectively investigated the relation between the apolipoprotein E genotype, dementia, and the accumulation of beta-amyloid protein in the cerebral cortex. METHODS Autopsy involving neuropathological analysis and DNA analysis of frozen blood samples were performed in 92 of 271 persons who were at least 85 years of age, who had been living in Vantaa, Finland, on April 1, 1991, and who had died between that time and the end of 1993. All subjects had been tested for dementia. Apolipoprotein E genotyping was done with a solid-phase minisequencing technique. The percentage of the cortex occupied by methenamine silver-stained plaques was used as an estimate of the extent of beta-amyloid protein deposition. RESULTS The frequency of the epsilon 4 allele was significantly higher in the subjects with Alzheimer's disease than in the subjects without dementia (30 percent vs. 8 percent, P < 0.001). There was a greater accumulation of beta-amyloid protein in the brain and more neurofibrillary tangles in the subjects with the epsilon 4 allele than in those without it (P < 0.001). The deposition of beta-amyloid protein varied according to the genotype in both the subjects with dementia and those without dementia: it was lowest in those with the epsilon 2/epsilon 3 genotype, intermediate in those with the epsilon 3/epsilon 3 genotype, and highest in those with the epsilon 3/epsilon 4 genotype. A single subject had the epsilon 4/epsilon 4 genotype and had dementia. CONCLUSIONS The epsilon 4 allele of apolipoprotein E is significantly associated with Alzheimer's disease. Even in elderly subjects without dementia, the apolipoprotein E genotype is related to the degree of deposition of beta-amyloid protein in the cerebral cortex.
This paper references
10.1212/WNL.34.7.939
Clinical diagnosis of Alzheimer's disease
G. Mckhann (1984)
10.1016/0002-8703(87)90610-7
Apolipoprotein E polymorphism in health and disease.
G. Utermann (1987)
10.1126/SCIENCE.3283935
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
R. Mahley (1988)
10.1111/j.1699-0463.1988.tb05320.x
Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
H. Gundersen (1988)
10.1111/j.1365-2990.1989.tb01252.x
EARLY SENILE PLAQUES IN DOWN'S SYNDROME BRAINS SHOW A CLOSE RELATIONSHIP WITH CELL BODIES OF NEURONS
D. Allsop (1989)
10.1212/WNL.41.4.479
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
S. S. Mirra (1991)
10.1016/0006-8993(91)91092-F
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
Y. Namba (1991)
10.1016/0304-3940(92)90444-C
Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
T. Wisniewski (1992)
Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing.
A. C. Syvänen (1993)
10.1016/0140-6736(93)92404-H
Apolipoprotein E-∈A allele and Alzheimer's disease
N. Anwar (1993)
10.1016/0140-6736(93)91705-Q
Apolipoprotein E polymorphism and Alzheimer's disease
J. Poirier (1993)
10.1006/BBRC.1993.1423
Apolipoprotein E : binding to soluble Alzheimer's β-amyloid
T. Wisniewski (1993)
10.1016/0140-6736(93)91458-X
Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19
D. Borgaonkar (1993)
10.1016/0140-6736(93)91728-5
Apolipoprotein E genotype and Alzheimer's disease
Shigeji Noguchi (1993)
10.1073/PNAS.90.5.1977
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
G. W. Rebeck (1993)
10.1073/PNAS.90.20.9649
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
D. Schmechel (1993)
10.3109/10520299309104677
Staining senile plaques using Bodian's method modified with methenamine.
H. Kondoh (1993)
10.1212/WNL.43.8.1467
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
A. Saunders (1993)
10.1016/0140-6736(93)92405-I
Movement of the rhabditiform larva of Strongyloides stercoralis
JoaoGustavo dos Santos (1993)
10.1126/SCIENCE.8346443
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E. Corder (1993)
10.1212/WNL.43.2.250
Vascular dementia
G. C. Román (1993)
10.1016/0140-6736(93)91709-U
Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
A. Saunders (1993)
10.1073/PNAS.90.17.8098
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
W. Strittmatter (1993)
10.1126/SCIENCE.8290965
Alzheimer's disease and possible gene interaction.
P. St George-Hyslop (1994)
10.1001/JAMA.1994.03510410028015
Alzheimer's disease, apolipoprotein E4, and gender.
H. Payami (1994)
10.1038/NG0694-180
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
E. Corder (1994)
10.1136/bmj.309.6955.636
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study
J. Kuusisto (1994)
10.1006/exnr.1994.1019
Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype
W. Strittmatter (1994)
Isoform-specific binding of apolipoprotein E to beta-amyloid.
M. LaDu (1994)
10.1016/S0140-6736(94)92960-2
Clinical application of apolipoprotein E genotyping to Alzheimer's disease
A. Roses (1994)
10.1016/S0140-6736(94)92557-7
Protection against Alzheimer's disease with apoE ∈2
C. Talbot (1994)
10.1016/0304-3940(94)90385-9
APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease
C. Broeckhoven (1994)
10.1161/01.ATV.14.7.1084
Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians.
J. Louhija (1994)
10.1016/0304-3940(94)90026-4
Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus
H. Houlden (1994)
10.1212/WNL.45.5.903
Lack of association of apolipoprotein E allele ϵ4 with late‐onset Alzheimer's disease among Finnish centenarians
E. Sobel (1995)
10.1006/BBRC.1995.1389
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
P. Richey (1995)



This paper is referenced by
10.34172/aim.2021.35
Prospects of Saffron and its Derivatives in Alzheimer's Disease.
Nadia Zandi (2021)
10.3389/fchem.2021.741037
Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From Acorus Calamus Plant Extract
Sushma Pradeep (2021)
10.1002/glia.24105
Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.
Caden M Henningfield (2021)
10.1101/2021.10.07.21264646
Leveraging large multi-center cohorts of Alzheimer Disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
M. Ali (2021)
10.1038/s41380-021-01249-0
The Amyloid-β Pathway in Alzheimer’s Disease
H. Hampel (2021)
10.31083/j.jin2002027
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
Feng Xing (2021)
10.1039/D0NA00801J
Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1–42)
H. Abbasi (2021)
10.1038/s41398-020-01137-1
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
P. Chatterjee (2020)
10.1016/j.biopsych.2020.07.025
Brain Amyloid Deposition in Late-Life Depression
N. Pomara (2020)
10.1080/13543784.2021.1849138
Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD
M. Sabbagh (2020)
10.1016/J.NEUROBIOLAGING.2021.06.004
Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease
Jin Ho Jung (2021)
10.1016/j.cca.2021.05.011
The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis.
K. Kirmess (2021)
10.3233/jad-200829
Cerebrovascular and Neurodegenerative Pathologies in Long-Term Stable Mild Cognitive Impairment.
Manu J. Sharma (2021)
10.1101/2021.03.28.437389
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson (2021)
10.1016/j.jneuroim.2020.577315
Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin
David Graykowski (2020)
10.1111/jnc.15128
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults
P. Chatterjee (2020)
10.3390/nu12051528
Meat Consumption, Cognitive Function and Disorders: A Systematic Review with Narrative Synthesis and Meta-Analysis
Huifeng Zhang (2020)
10.1186/s13024-020-0358-9
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Tosha Williams (2020)
10.1186/s12881-020-01046-6
Quantitative phenotype scan statistic (QPSS) reveals rare variant associations with Alzheimer’s disease endophenotypes
Y. Katsumata (2020)
Bioinformatic Study of gamma-Secretase and its Substrates
Fei Nan (2020)
10.1016/j.neuroscience.2019.08.037
Regulation of Alzheimer's disease-associated proteins during epileptogenesis
Eva-Lotta von Rüden (2020)
10.1016/j.pneurobio.2020.101804
The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling
Christopher Lee (2020)
10.3389/fphys.2020.00683
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
D. Liccardo (2020)
10.3233/JAD-200162
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load
P. Chatterjee (2020)
Finnish neuroscience from past to present
J. Kere (2020)
10.1186/s13195-020-00585-7
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
K. Minta (2020)
10.3348/JKSR.2020.81.3.488
알츠하이머 치매와 미세뇌혈관병리: 혈액뇌장벽 투과도 영상
문 원진 (2020)
10.3390/ijms21207784
Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
S. Thakran (2020)
10.1177/0271678X20952012
Hippocampal blood–brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia
W. Moon (2020)
10.3233/JAD-191023
Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.
Chenjia Xu (2020)
10.1111/ejn.14693
Finnish neuroscience from past to present
E. Korpi (2020)
10.1136/bmj.m3684
Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
Jiong Shi (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar